top of page

CHO-K1/Human P2Y4 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0182A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)


Product Description


The P2Y4 receptor is a Gq protein-coupled receptor primarily activated by the pyrimidine nucleotide UTP, belonging to the purinergic P2Y receptor family. Its ligand selectivity exhibits significant species differences: the human P2Y4 receptor is UTP-selective and insensitive to ATP, while the rodent ortholog can be equally activated by both UTP and ATP. This receptor is widely distributed in the central nervous system, heart, placenta, gastrointestinal tract, as well as airway epithelium and vascular endothelium. Its core function involves activating phospholipase C to mobilize intracellular calcium, thereby regulating transepithelial chloride and potassium secretion, controlling intestinal salt and water transport, participating in cardiac development and cardioprotection, and modulating neuronal excitability and neuropeptide release (such as vasopressin and orexin) in the central nervous system .

 

Screeningbio’s CHO-K1/Human P2Y4 cell line overexpress P2RY4 receptor and is designed to detect increases in intracellular IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

P2RY4

Accession Number

SNB-G-0182A

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human P2Y4 Agonist Assay. CHO-K1/Human P2Y4 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.
CHO-K1/Human P2Y4 Agonist Assay. CHO-K1/Human P2Y4 cells were treated with the reference agonist. The assay was run based on Revvity IP-one HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 /IC50 values were determined, using GraphPad Prism software.


Target Background


The P2Y4 receptor is a Gq protein-coupled receptor primarily activated by the pyrimidine nucleotide UTP, belonging to the purinergic P2Y receptor family. Its ligand selectivity exhibits significant species differences: the human P2Y4 receptor is UTP-selective and insensitive to ATP, while the rodent ortholog can be equally activated by both UTP and ATP.


This receptor is widely distributed in the central nervous system, heart, placenta, gastrointestinal tract, as well as airway epithelium and vascular endothelium. Its core function involves activating phospholipase C to mobilize intracellular calcium, thereby regulating transepithelial chloride and potassium secretion, controlling intestinal salt and water transport, participating in cardiac development and cardioprotection, and modulating neuronal excitability and neuropeptide release (such as vasopressin and orexin) in the central nervous system.

Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page